MNKD 8-K 2026-11-05

MANNKIND CORP (MNKD) 8-K dated 2026-11-05 — accession 0001193125-26-449743.

MANNKIND CORP (MNKD) is a biotechnology company listed on US.

MANNKIND CORP filed a 8-K on 2026-11-05. Accession 0001193125-26-449743.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported MNKD revenue for 2025-12-31 was $349.0M. Net income was $5.9M. Revenue was up 22.2% from 2024-12-31 to 2025-12-31. MNKD currently screens at market cap $1.28B.

Not investment advice. The MNKD SEC hub lists recent forms. The stock page is the research view.